Urolithiasis
Conditions
Keywords
PCNL, MPCNL, guidance, puncture
Brief summary
Purpose: The aim of this present study is to compare the result of fluoroscopy, ultrasonography (US) and US combined with fluoroscopy in the guidance of minimally invasive percutaneous nephrolithotomy (MPCNL). Methods: The investigators will enroll 450 patients who are candidates for MPCNL in our study. By simple random sampling technique, patients will be assigned to three 150-patient groups (group 1, US-guided MPCNL, group 2, fluoroscopy-guided MPCNL and group 3, US combined with fluoroscopy-guided MPCNL). In addition to approaches in guidance of MPCNL, the rest of the procedure is the same in all three groups.The end point of the study is the comparison of outcome of procedure including stone free rate, transfusion rate, operation time, access time, length of stay and complications.
Detailed description
Purpose: Recently, PCNL or MPCNL is widely used as the most popular choice to treat patients with all types of renal stones. Successful puncture to the desired renal calyx is the key step for the operation. Nowadays puncture for renal access can be achieve using not only US guidance but fluoroscopy guidance as well. However, it is clear that there is a lack of randomized controlled data comparing fluoroscopy, US and US combined with fluoroscopy in the guidance of MPCNL. Consequently, we performed this randomized controlled trial to obtain higher grade evidence.The aim of this present study is to compare the result of fluoroscopy, US and US combined with fluoroscopy in the guidance of MPCNL. Methods: We will enroll 450 patients who are candidates for MPCNL in our study. By simple random sampling technique, patients will be assigned to three 150-patient groups (group 1, US-guided MPCNL, group 2, fluoroscopy-guided MPCNL and group 3, US combined with fluoroscopy-guided MPCNL). All the patients will be diagnosed definitely before operations with kidney, ureter, and bladder (KUB), intravenous pyelography (IVP), US and/or CT. All procedures are performed by urologists in our center, with assistance from an endourology fellow. Surgical technique: Under general or epidural anaesthesia, each patient is initially placed in the lithotomy position, and a 5 Fr ureteric catheter is advanced to the kidney and fixed with a 16 Fr Foley catheter. Then the patient is turned to the prone position. Group 1: US-guided MPCNL The puncture is made with an 18-gauge needle using an ultrasound probe. After the desirable calix is reached, a flexible-tip guidewire is introduced. We attempt to manipulate the guidewire down to the ureter. If this is not successful, the second choice is to allow the guidewire to coil in a more distant calix. The length of the needle from skin to the collecting system is measured to ensure that the length of dilator is appropriate. The access tract is dilated from 8 Fr to a maximum 18/20 Fr using fascial dilator. We defined access to the collecting system as gaining entry to the targeted urinary system and desired calix. Lithotripsy is performed using either pneumatic lithotriptor or holmium laser. When multiple nephrostomy tracts are necessary to remove the stones, same technique is employed for each of the tracts. Complete stone clearance is confirmed using US at completion of the procedure. We routinely put a double J ureteral catheter into the ureter which is to be removed about 3-4 weeks later after the operation in the out-patients clinic. At the end of the procedure nephrostomy tubes are placed in both groups. The tubes are removed when the drainage from nephrostomy tubes being grossly clear. Group 2 fluoroscopy-guided MPCNL Patients in group 2 have the standard fluoroscopy-guided renal access before MPCNL. Air or contrast medium is injected through the ureteral catheter, the target calix is identified. For tract dilatation fascial dilators are used under fluoroscopic guidance. Complete stone clearance is confirmed fluoroscopically at completion of the procedure. The rest of the procedure is the same as described for patients in group 1. Group 3 US combined with fluoroscopy-guided MPCNL: Under the guidance of ultrasound, the coaxial needle is placed in the desired calyx. A floppy-tipped guidewire is then passed through the needle into the collecting system. The working channel is then dilated under X-ray. US and X-ray check for residual stone fragments are performed at the end of the procedure. The rest of the procedure is the same as described for patients in group 1. Data collection: Data for the three groups -demographic characteristics, access success, access time, duration of radiation exposure, site of target calix, site of access, Hb decrease, duration of postoperative hospital stay, complications (modified Clavien system), stone clearance (SFR after single procedure and final SFR) and the need for auxiliary treatment - are compared. The primary end point of the study is the comparison of outcome of procedure including stone free rate, transfusion rate, operation time, access time, length of stay and complications.
Interventions
Patients undergo MPCNL using only US-guided renal access.
Patients undergo MPCNL using only fluoroscopy-guided renal access.
Patients undergo MPCNL using US combined with fluoroscopy-guided renal access
Sponsors
Study design
Eligibility
Inclusion criteria
* Normal renal function. * American society of Anesthesiology (ASA) score 1 and 2. * Absence of congenital abnormalities. * Kidney stones of diameter \> 2.0cm (including multiple and staghorn stones)
Exclusion criteria
* Patients with congenital anomalies, e.g. ectopic kidney, polycystic, horseshoe, or malrotated kidney. * Patients who underwent transplant or urinary diversion. * Patients with solitary kidney. * Patients will be excluded from the study if they undergoing MPCNL have purulent fluid in the initial puncture.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stone Free Rate | one day after MPCNL | Stone-free status is assessed by kidneys-ureter-bladder (KUB) or/ and noncontrast CT at day 1 after MPCNL. A stone-free state is defined as no residual stones of diameter \>4 mm. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Perioperative Complications | intraoperatively or ≤ 30 days postoperatively | Complication is defined as any adverse event occurred intraoperatively or ≤ 30 days postoperatively. Complications included fever, systemic Inflammatory Response Syndrome, septic shock, extravasations, bleeding necessitating transfusion, and sever bleeding necessitating selective renal artery embolization. |
| Operation Time | intraoperatively | Operation time is defined as the time from puncture to the placement of the nephrostomy tube. |
| Change in Hemoglobin Concentration | within 24 hours after MPCNL | Change in hemoglobin concentration is assessed by comparing the preoperative hemoglobin level with 24-hour postoperative hemoglobin level. |
Countries
China
Participant flow
Recruitment details
A prospective and randomized study was performed with patient enrollment from July 2014 to May 2015 in the First Affilated Hospital of Guangzhou Medical University. 450 patients were then randomized into three groups. 12 patients had purulent fluid in the kidney at initial punctures. These 12 patients were excluded from the analysis.
Pre-assignment details
549 consecutive patients were assessed for eligibility, 99 were excluded for not meeting the inclusion criteria.
Participants by arm
| Arm | Count |
|---|---|
| US-guided Group Patients in US-guided group undergo MPCNL using only US-guided renal access. | 147 |
| Fluoroscopy-guided Group Patients in Fluoroscopy-guided group undergo MPCNL using only fluoroscopy-guided renal access. | 145 |
| Combined-guided Group Patients in Combined-guided group undergo MPCNL using US combined with fluoroscopy-guided renal access. | 146 |
| Total | 438 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Physician Decision | 3 | 5 | 4 |
Baseline characteristics
| Characteristic | US-guided Group | Fluoroscopy-guided Group | Combined-guided Group | Total |
|---|---|---|---|---|
| Age, Continuous | 49.9 years STANDARD_DEVIATION 10.9 | 49.6 years STANDARD_DEVIATION 11.3 | 48.8 years STANDARD_DEVIATION 11.3 | 49.4 years STANDARD_DEVIATION 11.1 |
| Region of Enrollment China | 147 participants | 145 participants | 146 participants | 438 participants |
| Sex: Female, Male Female | 61 Participants | 68 Participants | 58 Participants | 187 Participants |
| Sex: Female, Male Male | 86 Participants | 77 Participants | 88 Participants | 251 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — |
| other Total, other adverse events | 17 / 147 | 31 / 145 | 20 / 146 |
| serious Total, serious adverse events | 0 / 147 | 0 / 145 | 0 / 146 |
Outcome results
Stone Free Rate
Stone-free status is assessed by kidneys-ureter-bladder (KUB) or/ and noncontrast CT at day 1 after MPCNL. A stone-free state is defined as no residual stones of diameter \>4 mm.
Time frame: one day after MPCNL
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| US-guided Group | Stone Free Rate | 81 Participants |
| Fluoroscopy-guided Group | Stone Free Rate | 91 Participants |
| Combined-guided Group | Stone Free Rate | 98 Participants |
Change in Hemoglobin Concentration
Change in hemoglobin concentration is assessed by comparing the preoperative hemoglobin level with 24-hour postoperative hemoglobin level.
Time frame: within 24 hours after MPCNL
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| US-guided Group | Change in Hemoglobin Concentration | 12.9 g/L | Standard Deviation 16 |
| Fluoroscopy-guided Group | Change in Hemoglobin Concentration | 14.5 g/L | Standard Deviation 10 |
| Combined-guided Group | Change in Hemoglobin Concentration | 13.1 g/L | Standard Deviation 10.8 |
Operation Time
Operation time is defined as the time from puncture to the placement of the nephrostomy tube.
Time frame: intraoperatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| US-guided Group | Operation Time | 60.6 min | Standard Deviation 32.9 |
| Fluoroscopy-guided Group | Operation Time | 63.6 min | Standard Deviation 32.5 |
| Combined-guided Group | Operation Time | 66.3 min | Standard Deviation 34.7 |
Perioperative Complications
Complication is defined as any adverse event occurred intraoperatively or ≤ 30 days postoperatively. Complications included fever, systemic Inflammatory Response Syndrome, septic shock, extravasations, bleeding necessitating transfusion, and sever bleeding necessitating selective renal artery embolization.
Time frame: intraoperatively or ≤ 30 days postoperatively
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| US-guided Group | Perioperative Complications | 17 Participants |
| Fluoroscopy-guided Group | Perioperative Complications | 31 Participants |
| Combined-guided Group | Perioperative Complications | 20 Participants |